Holen Sie sich die Stockscreener-App
1.70
1.80%
0.03
Schlusskurs vom Vortag:
$1.67
Offen:
$1.68
24-Stunden-Volumen:
466.51K
Relative Volume:
0.62
Marktkapitalisierung:
$181.35M
Einnahmen:
$45.44M
Nettoeinkommen (Verlust:
$-35.43M
KGV:
-5.00
EPS:
-0.34
Netto-Cashflow:
$-25.39M
1W Leistung:
-0.58%
1M Leistung:
+4.29%
6M Leistung:
-22.37%
1J Leistung:
-52.91%
1-Tages-Spanne:
$1.65
$1.73
1-Wochen-Bereich:
$1.61
$1.805
52-Wochen-Spanne:
$1.26
$5.20
Maxcyte Inc Stock (MXCT) Company Profile
Firmenname
Maxcyte Inc
Sektor
Branche
Telefon
301-517-5556
Adresse
9713 KEY WEST AVENUE,, ROCKVILLE
Vergleichen Sie MXCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.70 | 178.15M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
128.05 | 221.17B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.36 | 145.34B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
375.08 | 141.58B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.35 | 132.37B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.82 | 49.16B | 5.88B | 1.34B | 799.60M | 2.3489 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | Eingeleitet | Stephens | Overweight |
| 2023-11-29 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | BTIG Research | Buy |
| 2021-08-24 | Eingeleitet | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | Stephens | Overweight |
| 2021-08-24 | Eingeleitet | Stifel | Buy |
| 2021-08-24 | Eingeleitet | Wedbush | Outperform |
| 2021-08-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Maxcyte Inc Aktie (MXCT) Neueste Nachrichten
MaxCyte aims to optimize CAR T manufacturing with ExPERT system - Traders Union
MaxCyte (NASDAQ:MXCT) Stock Rating Upgraded by Wall Street Zen - Defense World
MaxCyte: Building the Future of Cell and Gene Therapy Innovation - MSN
What drives MaxCyte Inc MYE0 stock priceRSI Overbought/Oversold & Daily Tips From Top Market Analysts - earlytimes.in
How MaxCyte Inc. (MYE0) stock reacts to fiscal policiesJuly 2025 Market Mood & Safe Entry Point Alerts - newser.com
Can MaxCyte Inc. (MYE0) stock reach $200 price target2025 Major Catalysts & Weekly High Return Opportunities - newser.com
How MaxCyte Inc. (MYE0) stock behaves under inflation pressureEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
MaxCyte explores electroporation's role in cell therapy innovation - Traders Union
What Wall Street predicts for MaxCyte Inc. stock priceQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
MaxCyte drives cell engineering focus at Advanced Therapies USA - Traders Union
Can MaxCyte Inc. (MYE0) stock stage a strong rebound this quarter2025 Key Lessons & Daily Technical Forecast Reports - newser.com
MaxCyte Announces Major Workforce Reduction Plan - MSN
Is MaxCyte Inc. stock a buy in volatile marketsJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
MaxCyte at Stephens Annual Investment Conference: Strategic Restructuring Amid Market Challenges By Investing.com - Investing.com Canada
Will MaxCyte Inc. stock split again soonTrade Risk Report & Daily Profit Maximizing Tips - newser.com
A Look at MaxCyte Inc (MXCT) Shares in the Recent Past Indicates Growth - Setenews
Is MaxCyte Inc. (MYE0) stock nearing a technical breakoutPortfolio Gains Summary & Community Consensus Picks - newser.com
What dividend safety rating applies to MaxCyte Inc. (MYE0) stockIPO Watch & Safe Capital Growth Trade Ideas - newser.com
How MaxCyte Inc. (MYE0) stock trades under stagflation2025 Performance Recap & Entry Point Strategy Guides - newser.com
FY2025 EPS Estimates for MaxCyte Boosted by William Blair - Defense World
Will MaxCyte Inc. (MYE0) stock see valuation expansionJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
How buyback programs support MaxCyte Inc. (MYE0) stockTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
What MACD signals say about MaxCyte Inc.July 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Real time scanner hits for MaxCyte Inc. explainedJuly 2025 Breakouts & Free Community Consensus Stock Picks - newser.com
Statistical indicators supporting MaxCyte Inc.’s strengthWeekly Trade Recap & Weekly Return Optimization Alerts - newser.com
Will breakout in MaxCyte Inc. lead to full recoveryPortfolio Growth Summary & Real-Time Stock Price Movement Reports - newser.com
MaxCyte, Inc. (NASDAQ:MXCT) Q3 2025 Earnings Call Transcript - Insider Monkey
Backtesting results for MaxCyte Inc. trading strategiesPortfolio Growth Summary & AI Driven Stock Reports - newser.com
Finanzdaten der Maxcyte Inc-Aktie (MXCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.57%
1.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):